Voluntary Withdrawals of Helixate FS & Kogenate FS

As part of HFA’s ongoing mission to assist and advocate for the bleeding disorders community, this medical news is being issued to keep you informed about product safety.About These WithdrawalsCSL Behring is initiating a voluntarily recall of two lots of its hemophilia A drug Helixate FS containing active ingredient manufactured before November 2015. As part […]

Adynovate Phase 3 Efficacy and Safety Data in Children to be Presented

Note: The below is an edited version of an article originally published on PR Newswire. The original release can be read in it’s entirety here._________________________________________________________________________________________Shire will present additional data on the clinical experience of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated], an extended half-life recombinant Factor VIII (rFVIII) replacement for hemophilia A, during the International Congress of […]

CSL Behring Presents Phase III Data for IDELVION for Hemophilia B

Note: The below is an edited version of an article originally published on Yahoo Finance. The original release can be read in it’s entirety here._________________________________________________________________________________________CSL Behring announced new data today from its Phase III PROLONG-9FP clinical development program evaluating IDELVION® [Coagulation Factor IX (Recombinant), Albumin Fusion Protein], the company’s long-acting recombinant albumin fusion protein for treating […]

Alnylam Announces New Positive Interim Phase 1 Study Results for Fitusiran

Note: The below is an edited version of an article originally published on StreetInsider.com. The original release can be read in it’s entirety here._________________________________________________________________________________________Alnylam Pharmaceuticals, Inc. announced today new positive results from its ongoing Phase 1 study with Fitusiran, an investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B and rare bleeding […]

Infusing Love: Defining Normal

“How do you do it?”“Isn’t it difficult?”“Do you feel as though you need to wrap him in bubble wrap?”“How do you handle all of it?” Most bleeding disorders moms have had to answer those questions or something similar to them. Questions of that nature do not surprise me anymore, because what parenting looks like for […]

Novo Nordisk Announces New Data on Psychosocial Impact of People Living with Hemophilia B

Note: The below is an edited version of a press release by Novo Nordisk. The original release can be read in it’s entirety here.  Novo Nordisk today announced the first results from the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study, which found that many adults and children living with even mild or […]